HIVClinicalForum
Meeting category
Date(s)
12 Sep 2017
Location
Rio de Janeiro, Brazil
Organizer

Brazilian HIV Clinical Forum 2017

Related Enduring Materials

Enduring Materials
Session 1: Basic Characteristics of Integrase Inhibitors -
Resistance Characteristics of HIV Integrase Inhibitors
Charles Boucher, MD, PhD
Erasmus Medical Center, The Netherlands
Is Baseline Resistance Testing Needed?
Ricardo Diaz, MD
Federal University of Sao Paulo - UNIFESP, Brazil
Session 2: Brazilian Infectious Diseases Society -
Brazilian Guidelines for Antiretroviral Therapy
José Valdez Madruga, MD
CRT-DST / AIDS SP, Brazil
Clinical Case Discussion 1
Constant Vergara
Dr. T.R. Constant Vergara
Clínica Geral , Rio de Janeiro
Clinical Case Discussion 2
Estevão Nunes
Estevão Portela Nune
Evandro Chagas Clinical Research Institute (IPEC)– FIOCRUZ , Rio de Janeiro
Clinical Case Discussion 3
placeholder3
Dr. M.C.Rachid de Lacerda
Conselho Regional de Medicina do Estado do Rio de Janeiro (CREMERJ) , Rio de Janeiro
Session 3: Integrase Inhibitors in Special Populations -
The Role of HIV Integrase Inhibitors in PrEP & PEP
Richard Elion
Richard Elion
Whitman-Walker Health , Washington DC
HIV Integrase Inhibitors in an Aging Population (Polypharmacy - Comorbidities)
placeholder3
Dr. M.C.Rachid de Lacerda
Conselho Regional de Medicina do Estado do Rio de Janeiro (CREMERJ) , Rio de Janeiro
Clinical Case on Integrase Inhibitors Use in TB-Infected Patients
placeholder3
Dr. L. Grinsztejn
Evandro Chagas Clinical Research Institute (IPEC)– FIOCRUZ , Rio de Janeiro